All ESC European Society of Cardiology Guidelines:

https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines

Acute Coronary Syndromes

ACC/AHA/ACEP/NAEMSP/SCAI (2025): Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines (ahajournals.org)
NICE (2020): Acute coronary syndromes (nice.org.uk)
ESC (2023): Guidelines for the management of aute coronary syndromes (escardio.org)

Acute Myocardial Infarction STEMI

ACC/AHA (2013): 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction | Circulation (ahajournals.org)
AHA (2018): Fourth Universal Definition of Myocardial Infarction (2018) | Circulation (ahajournals.org)

Assessing and Prescribing Exercise in Clinical Practice for those with Cardiovascular Disease

AHA (2016): Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association (ahajournals.org)
ESC (2020): 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease (escardio.org)
EAPC (2021): Exercise intensity assessment and prescription in cardiovascular rehabilitation and beyond: why and how: a position statement from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology | European Journal of Preventive Cardiology | Oxford Academic
2024 Practical Guidelines for Exercise Prescription in Patients with Chronic Heart Failure
CSANZ (2023) A Clinical Guide for Assessment and Prescription of Exercise and Physical Activity in Cardiac Rehabilitation. A CSANZ Position Statement – Heart, Lung and Circulation
AHA & ACC (2025): Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) (2025): Volume of Aerobic Exercise to Optimize Outcomes in Cardiac Rehabilitation: An Official Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation

Atrial Fibrillation

ACC/AHA (2019): 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation (jacc.org)
ESC (2024): ESC Guidelines for the management of atrial fibrillation (escardio.org)
NICE (2024): Overview | Atrial fibrillation: diagnosis and management | Guidance | NICE

Cardiac Rehabilitation Guidelines Accessible On-line:

American Heart Association (2024) Core Components of Cardiac Rehabilitation Programs
Australian Cardiovascular Health and Rehabilitation ACRA (2019)
British Association For Cardiovascular Prevention and Rehabilitation BACPR (2023)
Brazilian Cardiovascular Rehabilitation Guidelines (2020)
Cardiac Rehabilitation Guidelines in German Speaking Countries of Europe (2021): Part 1 and Part 2
European Association of preventive Cardiology (EAPC) (2020) 
International Council of Cardiovascular Prevention and Rehabilitation (2016)
Portuguese Society of Cardiology Cardiac Rehabilitation Guidelines (2018)
Japanese Circulation Society (2022)
Clinical Practice Guideline for Cardiac Rehabilitation in Korea: Recommendations for Cardiac Rehabilitation and Secondary Prevention after Acute Coronary Syndrome (2019)
Cardiac Society New Zeland CSANZ (2021)
Scottish Intercollegiate Guidelines Network (SIGN) (2017)
Taiwan Myocardial Infarction Society (TAMIS), Taiwan Society of Cardiology (TSOC), and Taiwan Academy of Cardiovascular and Pulmonary Rehabilitation (TACVPR) (2023)
World Health Organisation: (2023)

Cardiac Pacing and Cardiac Resynchronisation Therapy

ESC (2021): 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
NICE (2014): implantable-cardioverter-defibrillators-and-cardiac-resynchronisation-therapy-for-arrhythmias-and-heart-failure-pdf-82602426443461 (nice.org.uk)

Cardiovascular Disease: Risk Assessment and Reduction

(NICE 2023): Overview | Cardiovascular disease: risk assessment and reduction, including lipid modification | Guidance | NICE (nice.org.uk)
ESC (2021): 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice (escardio.org)
EAPC (2020): Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology

Chronic Coronary Syndromes

AHA/ACC/ACCP/ASPC/NLA/PCNA (2023): Guideline for the Management of Patients With Chronic Coronary Disease
ESC (2024): Guidelines for the management of chronic coronary syndromes (escardio.org)
NICE (2016): Stable angina: management

Congenital Heart Disease - Adult

ACC/AHA (2018): https://www.jacc.org/doi/pdf/10.1016/j.jacc.2018.08.1029?_ga=2.59830437.961823324.1612364563-2065205337.1612364563
ESC (2020): ESC Guidelines on Grown-Up Congenital Heart Disease (GUCH) (Management of) (escardio.org)

Diabetes and Cardiovascular Disease

ESC (2023): 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes (escardio.org)
AHA (2022): Comprehensive Management of Cardiovascular Risk Factors for Adults With Type 2 Diabetes: A Scientific Statement From the American Heart Association | Circulation

Dual Antiplatelet Therapy

ESC (2017): ESC Guidelines on Dual Antiplatelet Therapy (DAPT) (escardio.org)

Dyslipidaemia

ACC/AHA (2018): 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (jacc.org)
ESC (2019): ESC Guidelines on Dyslipidaemias (Management of) (escardio.org)
NICE (2016): Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia (nice.org.uk)
NICE (2016): Evolocumab for treating primary hypercholesterolaemia and mixed dyslipidaemia (nice.org.uk)

European Society of Cardiology Handbook of Cardiovascular Rehabilitation

ESC (2020): A practical clinical guide: https://academic.oup.com/esc/book/31780

Heart Failure

AHA (2022): 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines | Circulation
ESC (2021): 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (escardio.org)
NICE (2021): Acute heart failure: diagnosis and management (nice.org.uk)
NICE (2018): Chronic heart failure in adults: diagnosis and management (nice.org.uk)

Hypertension

AHA ( 2024): The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association
AHA (2024): Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association | Hypertension
AHA (2024): Orthostatic Hypotension in Adults With Hypertension: A Scientific Statement From the American Heart Association
AHA (2021): Medication Adherence and Blood Pressure Control: A Scientific Statement From the American Heart Association
AHA (2021): Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement From the American Heart Association
WHO (2021): Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary
ESC(2024): 2024 ESC Guidelines for the management of elevated blood pressure and hypertension
NICE (2023): Hypertension in adults: diagnosis and management

Cardiomyopathy

ESC (2023): 2023 ESC Guidelines for the management of cardiomyopathies
AHA (2024): 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
AHA (2016): Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies

Management of Overweight/Obese Adults

Obesity Canada (2020): Canadian Adult Obesity Clinical Practice Guideline
NICE (2025): Overweight and obesity management (nice.org.uk)
Collaboration incl HSE (2022) Obesity in Adults: A 2022 Adapted Clinical Practice Guideline for Ireland

Peripheral Vascular Disease

AHA (2022): Advancing Peripheral Artery Disease Quality of Care and Outcomes Through Patient-Reported Health Status Assessment: A Scientific Statement From the American Heart Association
AHA (2018): Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association
ESC (2024): ESC Guidelines for the management of peripheral arterial and aortic diseases
NICE (2020): Peripheral arterial disease: diagnosis and management

Supraventricular Arrhythmias

ACC/AHA (2015): https://www.jacc.org/doi/pdf/10.1016/j.jacc.2015.08.856?_ga=2.1152185.961823324.1612364563-2065205337.1612364563
ESC (2019): 2019 ESC Guidelines for the management of patients with supraventricular tachycardia (escardio.org)
The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)
NICE (2021): Recommendations | Atrial fibrillation: diagnosis and management | Guidance | NICE (nice.org.uk)

Ventricular Arrhythmia and the Prevention of Sudden Cardiac Death

ACC/AHA (2017): https://www.jacc.org/doi/pdf/10.1016/j.jacc.2017.10.054?_ga=2.67212441.961823324.1612364563-2065205337.1612364563
ESC (2022): ESC Guidelines on Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death (escardio.org)
NICE (2017): Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death (nice.org.uk)
NICE (2014): Overview | Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure | Guidance | NICE (nice.org.uk)

Resynchronisation and Pacemaker Devices

ESC (2021): 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy (escardio.org)
NICE (2014): Overview | Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure | Guidance | NICE (nice.org.uk)